[go: up one dir, main page]

NO20071008L - Fremgangsmate for fremstilling av N-piperidino-1,5-difenylpyrazol-3-karboksamidderivater - Google Patents

Fremgangsmate for fremstilling av N-piperidino-1,5-difenylpyrazol-3-karboksamidderivater

Info

Publication number
NO20071008L
NO20071008L NO20071008A NO20071008A NO20071008L NO 20071008 L NO20071008 L NO 20071008L NO 20071008 A NO20071008 A NO 20071008A NO 20071008 A NO20071008 A NO 20071008A NO 20071008 L NO20071008 L NO 20071008L
Authority
NO
Norway
Prior art keywords
diphenylpyrazole
piperidino
preparation
carboxamide derivatives
hydrogen atom
Prior art date
Application number
NO20071008A
Other languages
English (en)
Inventor
Marc Daumas
Philippe Vayron
Alain Dlubala
Raphael Sole
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of NO20071008L publication Critical patent/NO20071008L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Addiction (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

Det er beskrevet en fremgangsmåte for fremstilling av en forbindelse av formel (I), hvori: R1 betyr et hydrogenatom eller halogenatom eller en (C1-C4)alkylgruppe; R2, R3, R4, R5, R6 og R7 betyr uavhengig av hverandre, et hydrogenatom eller halogenatom eller en (C1-C4)alkyl, (C1-C4)alkoksy eller trifluorometylgruppe, så vel som salter derav.
NO20071008A 2004-07-22 2007-02-21 Fremgangsmate for fremstilling av N-piperidino-1,5-difenylpyrazol-3-karboksamidderivater NO20071008L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0408111A FR2873372B1 (fr) 2004-07-22 2004-07-22 Procede de preparation de derives n-piperidino-1,5- diphenylpyrazole-3-carboxamide
PCT/FR2005/001850 WO2006021652A1 (fr) 2004-07-22 2005-07-20 Procede de preparation de derives n-piperidino-1,5-diphenylpyrazole-3-carboxamide

Publications (1)

Publication Number Publication Date
NO20071008L true NO20071008L (no) 2007-02-21

Family

ID=34949586

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20071008A NO20071008L (no) 2004-07-22 2007-02-21 Fremgangsmate for fremstilling av N-piperidino-1,5-difenylpyrazol-3-karboksamidderivater

Country Status (21)

Country Link
US (1) US7462632B2 (no)
EP (1) EP1773783B1 (no)
JP (1) JP4879175B2 (no)
KR (1) KR20070036050A (no)
CN (1) CN100537543C (no)
AR (1) AR049995A1 (no)
AT (1) ATE466843T1 (no)
AU (1) AU2005276350A1 (no)
BR (1) BRPI0510399A (no)
CA (1) CA2564223A1 (no)
DE (1) DE602005021110D1 (no)
FR (1) FR2873372B1 (no)
IL (1) IL179107A0 (no)
MA (1) MA28576B1 (no)
MX (1) MXPA06012954A (no)
NO (1) NO20071008L (no)
RU (1) RU2329252C1 (no)
TW (1) TW200609223A (no)
UY (1) UY29023A1 (no)
WO (1) WO2006021652A1 (no)
ZA (1) ZA200609639B (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1816125A1 (en) * 2006-02-02 2007-08-08 Ranbaxy Laboratories, Ltd. Novel crystalline forms of an antagonist of CB1 cannabinoid receptor and preparation method thereof
WO2008026219A2 (en) * 2006-09-01 2008-03-06 Hetero Drugs Limited Novel polymorphs of rimonabant
WO2008032330A2 (en) * 2006-09-11 2008-03-20 Hetero Drugs Limited Improved process for rimonabant
WO2008035023A1 (en) * 2006-09-19 2008-03-27 Cipla Limited Polymorphs of rimonabant
EP1944297A1 (en) * 2007-01-09 2008-07-16 Miklós Vértessy Solid and crystalline rimonabant and processes for preparation, and pharmaceutical composition thereof
EP1947090A1 (en) * 2007-01-17 2008-07-23 Laboratorios del Dr. Esteve S.A. Method for preparing N-piperidino-1,5-diphenylpyrazole-3-carboxamide and derivatives
WO2008088900A2 (en) * 2007-01-18 2008-07-24 Teva Pharmaceutical Industries Ltd. Polymorphic forms of rimonabant base and processes for preparation thereof
WO2008102367A1 (en) * 2007-02-19 2008-08-28 Darmesh Mahendrabhai Shah Process for preparation of pyrazole derivatives
FR2913018A1 (fr) * 2007-02-23 2008-08-29 Sanofi Aventis Sa Solution solide amorphe contenant un derive de pyrazole-3-carboxamide sous forme amorphe et des excipients stabilisateurs
WO2009109222A1 (en) * 2008-03-04 2009-09-11 Maprimed, S. A. Process for the preparation of rimonabant
WO2010079241A1 (es) 2009-01-12 2010-07-15 Fundacion Hospital Nacional De Paraplejicos Para La Investigacion Y La Integracion Uso de antagonistas y/o agonistas inversos de los receptores cb1 para la preparación de medicamentos que incrementen la excitabilidad de las motoneuronas

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2713225B1 (fr) * 1993-12-02 1996-03-01 Sanofi Sa N-pipéridino-3-pyrazolecarboxamide substitué.
FR2714057B1 (fr) * 1993-12-17 1996-03-08 Sanofi Elf Nouveaux dérivés du 3-pyrazolecarboxamide, procédé pour leur préparation et compositions pharmaceutiques les contenant.
FR2789079B3 (fr) * 1999-02-01 2001-03-02 Sanofi Synthelabo Derive d'acide pyrazolecarboxylique, sa preparation, les compositions pharmaceutiques en contenant
JP4314339B2 (ja) * 2002-08-22 2009-08-12 三井化学アグロ株式会社 ニコチンアミドラゾン誘導体

Also Published As

Publication number Publication date
AU2005276350A1 (en) 2006-03-02
FR2873372B1 (fr) 2006-09-08
EP1773783A1 (fr) 2007-04-18
MXPA06012954A (es) 2007-02-12
ZA200609639B (en) 2008-08-27
KR20070036050A (ko) 2007-04-02
US7462632B2 (en) 2008-12-09
CN100537543C (zh) 2009-09-09
ATE466843T1 (de) 2010-05-15
TW200609223A (en) 2006-03-16
IL179107A0 (en) 2007-03-08
CA2564223A1 (fr) 2006-03-02
DE602005021110D1 (de) 2010-06-17
JP4879175B2 (ja) 2012-02-22
CN1956963A (zh) 2007-05-02
EP1773783B1 (fr) 2010-05-05
JP2008506756A (ja) 2008-03-06
AR049995A1 (es) 2006-09-20
UY29023A1 (es) 2006-02-24
RU2329252C1 (ru) 2008-07-20
US20080119653A1 (en) 2008-05-22
BRPI0510399A (pt) 2007-11-13
FR2873372A1 (fr) 2006-01-27
MA28576B1 (fr) 2007-05-02
WO2006021652A1 (fr) 2006-03-02

Similar Documents

Publication Publication Date Title
NO20071008L (no) Fremgangsmate for fremstilling av N-piperidino-1,5-difenylpyrazol-3-karboksamidderivater
SG160195A1 (en) N-phenyl-2-pyrimidine-amine derivatives
NO20053215L (no) Pyrazolderivater med anvendelse som COX-1-inhibitorer.
WO2009156861A8 (en) Substituted pyrimidone derivatives
MY142807A (en) Benzimidazole derivative and use thereof.
WO2008078686A1 (ja) オキシムエステル化合物及び該化合物を含有する光重合開始剤
NO20073956L (no) Pyrazolderivater for inhibering av CDK og GSK
TW200738667A (en) Preparation method for dioxan-2-ylalkylcarbamate derivatives and intermediate thereof
WO2008111441A1 (ja) 医薬組成物
NO20092770L (no) Nye aminopyrimidinderivater som PLK1-inhibitorer
WO2008136444A1 (ja) 縮合複素環誘導体
NO20080157L (no) Fremgangsmate for syntese av organiske forbindelser
TNSN06203A1 (en) Derivatives of n- (1,5-diphenyl-1h-pyrazol-3-yl) sulphonamide with cb1 receptor affinity
NO20054135L (no) Kipolinon/benzoksazin derivater og anvendelser derav
EP1854789A4 (en) QUINAZOLINE DERIVATIVE HAVING TYROSINE KINASE INHIBITORY ACTIVITY
NO20062491L (no) Benzoksazinderivter og deres anvendelse
TNSN08161A1 (en) 6-heteroarylpyridoindolone derivatives, their preparation and therapeutic use thereof
MX2010010471A (es) Derivado de tetrahidroisoquinolina novedoso.
TW200607808A (en) Pyrido-pyrimidine derivatives, preparation thereof and application thereof
NO20071253L (no) Fremgangsmate for syntese av C-2, C-3 substituerte N-alkylerte indoler anvendbare som CPLA2-inhibitorer.
NO20033131D0 (no) Anvendelse av 2-amino-4-pyridylmetyl-tiazolinderivater som inhibitorer forinducibel NO-syntase
NO20070972L (no) Benzyloksyderivater som MAOB-inhibitorer
WO2009057733A1 (ja) 血管新生阻害活性を有する新規インドール誘導体
NO20061832L (no) Karboksamidderivat av amidtype
NO20055695L (no) Tiadiazinforbindelser og anvendelse derav som positive AMPA-reseptormodulatorer

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application